Biological Immunology and Neurology

Gamunex-C

Payments companies reported to CMS as associated with Gamunex-C. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.1Massociated payments (2023-2025)
3,961clinicians with associated payments
2companies reporting

By year

2023 $355K
2024 $412K
2025 $324K

Payments reported as associated with Gamunex-C, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Neurology (Psychiatry & Neurology) $872K
Neuromuscular Medicine (Psychiatry & Neurology) $64K
Family $31K
Physician Assistant $15K
Clinical Neurophysiology $13K
Nurse Practitioner $12K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gamunex-C

These are the largest totals companies reported as associated with Gamunex-C. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Suraj Muley Phoenix, AZ Neurology (Psychiatry & Neurology) $156,542.68
Gil Wolfe Buffalo, NY Neurology (Psychiatry & Neurology) $116,764.42
Jonathan Katz San Francisco, CA Neurology (Psychiatry & Neurology) $58,629.92
John England New Orleans, LA Neurology (Psychiatry & Neurology) $57,078.98
Salman Bhai Dallas, TX Neurology (Psychiatry & Neurology) $48,535.41
Rossitza Chichkova Tampa, FL Neurology (Psychiatry & Neurology) $42,680.75
Samir Macwan Rancho Mirage, CA Neuromuscular Medicine (Psychiatry & Neurology) $42,073.18
Kourosh Rezania Chicago, IL Neurology (Psychiatry & Neurology) $29,056.46
Perry Shieh Los Angeles, CA Neurology (Psychiatry & Neurology) $26,013.96
Karissa Gable Durham, NC Neurology (Psychiatry & Neurology) $23,594.81

Prescribed Gamunex-C?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.